# Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

> **NCT05889312** · — · RECRUITING · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 32 (estimated)

## Conditions studied

- Cancer
- Diagnosis
- Resistant Cancer
- Response, Acute Phase

## Interventions

- **DIAGNOSTIC_TEST:** 18F-FSPG PET/CT in NSCLC
- **DIAGNOSTIC_TEST:** 18F-FSPG PET/CT in HNSCC

## Key facts

- **NCT ID:** NCT05889312
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-19
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889312, "Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05889312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*